Furthermore, Ruys et al. published a large meta-analysis with 4126 patients demonstrating that the biomarkers fascin, EGFR, MUC1, and MUC4 are associated with reduced survival in patients with resected ICC [23]. This evidence concerns the gene MUC4 and intrahepatic cholangiocarcinoma.